Health Catalyst HCAT 深 沪
已收盘 02-06 16:00:00 美东时间
2.15
+0.060
+2.87%
华盛通- 最 高2.18
- 今 开2.13
- 成交量 98.41万股
- 最 低 2.04
- 昨 收 2.09
- 总市值 1.52亿
- 52周最高 5.56
- 市盈率 静 --
- 换手率 1.39%
- 52周最低 2.015
- 委 比 -41.28%
- 总股本 7073.09万
- 历史最高 59.50
- 量 比 1.14
- 振 幅 6.70%
- 历史最低 2.015
- 每 手 1
- 风险率 0.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Health Catalyst Announces Chief Commercial Officer Transition Plan
Health Catalyst ( ($HCAT) ) has issued an announcement. On January 20, 2026, He...
01-24 06:25
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
4 Analysts Have This To Say About Health Catalyst
Across the recent three months, 4 analysts have shared their insights on Health...
01-10 05:01
Citigroup Maintains Neutral on Health Catalyst, Lowers Price Target to $2.75
Citigroup analyst Daniel Grosslight maintains Health Catalyst (NASDAQ:HCAT) with a Neutral and lowers the price target from $3.25 to $2.75.
01-10 00:01
Health Catalyst Appoints New Board Member Matt Arens
The latest update is out from Health Catalyst ( ($HCAT) ). On December 1, 2025,...
2025-12-02 20:28
Health Catalyst to Participate in Upcoming Investor Conferences
Health Catalyst, Inc. announced that senior management members, including Dan Burton, Ben Albert, Jason Alger, and Matt Hopper, will participate in several upcoming investor conferences. The events include the Stephens Annual Investment Conference in Nashville on November 19, the Canaccord Genuity MedTech Forum in New York on November 20, the Evercore Healthcare Conference in Miami on December 2, and Citi’s Global Healthcare Conference in Miami o...
2025-11-14 21:14
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
2025-11-12 11:43
Health Catalyst's Twistle By Health Catalyst, Lumeon By Health Catalyst, And Upfront By Health Catalyst Achieve HITRUST r2 Certification
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Twistle by Health Catalyst (Twistle),
2025-11-11 05:16
Health Catalyst Sees Q4 Sales $73.500M vs $76.016M Est
Health Catalyst (NASDAQ:HCAT) sees Q4 sales of $73.500 million vs $76.016 million analyst estimate.
2025-11-11 05:04
Health Catalyst Q3 Adj. EPS $0.06, Inline, Sales $76.323M Beat $75.900M Estimate
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is a 14.29 percent decrease over earnings of $0.07 per share from the same period last year.
2025-11-11 05:04
